ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha]
ENDRA Life Sciences Inc. (NDRA)
US:NASDAQ Investor Relations:
investors.endrainc.com/prviewer/release_only/id/2807436
Company Research
Source: Seeking Alpha
ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q3 2019 Results - Earnings Call Transcript ENDRA Life Sciences Inc. (NASDAQ: Company Participants Francois Michelon - Chairman and Chief Executive Officer David Wells - Chief Financial Officer Michael Thornton - Chief nology Officer Renaud Maloberti - Chief Commercial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Kyle Bauser - Dougherty & Company Vernon Bernardino - H.C. Wainwright Ed Woo - Ascendiant Capital Operator Good afternoon. My name is Cynthia and I will be your operator today. At this time, I would like to welcome everyone to the ENDRA Life Sciences’ Third Quarter 2019 Business Update and Financial Conference Call and Webcast. It is now my pleasure to turn today's call over to your host Mr. David Wells, ENDRA's Chief Financial Officer. You may begin, sir. Thank you, Cynthia. Good afternoon. Welcome to ENDRA's third quarter 2019 business update and financial conference call. We issued a pre
Show less
Read more
Impact Snapshot
Event Time:
NDRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDRA alerts
High impacting ENDRA Life Sciences Inc. news events
Weekly update
A roundup of the hottest topics
NDRA
News
- ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementBusiness Wire
- ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update [Yahoo! Finance]Yahoo! Finance
- ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business UpdateBusiness Wire
- Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024Business Wire
- ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European PatentBusiness Wire
NDRA
Sec Filings
- 11/21/24 - Form 10-Q/A
- 11/19/24 - Form 10-Q
- 11/15/24 - Form 8-K
- NDRA's page on the SEC website